Skip to content

Blog

Addressing the challenges of packaging OSD and powder products with low humidity and/or low oxygen requirements.

The pharmaceutical industry must live by the rules of the regulatory bodies such as the FDA, EMEA, and other organizations.  In the US Code…

Continue Reading

Blog

Trends in global drug supply: An interview with Sharp President, Kevin Orfan

On the Molecule to Market podcast, Sharp president Kevin Orfan discusses the importance of building robust and scalable systems and processes in a fast-growing…

Continue Reading

Blog

Clinical Trial & Commercial Packaging Trends & Predictions

Perhaps more than any other industry, pharma and biotech have undergone radical change in 2020 as a result of the COVID-19 pandemic. From supply…

Continue Reading

Blog

Need for speed: the key to successful multi-market product launches

Launching a new drug in the European marketplace presents a variety of unique challenges. Numerous official working languages, complex independent regulatory requirements combined with an overarching framework, and the intricacy and scale of distribution are all characteristics of an EU launch.

Continue Reading

Blog

Low-volume / small-batch packaging challenges (in both the US and EU)

Meeting the small-batch pharma packaging challenge Medications are becoming far more specialized and personalized and these specialty drug products continue to emerge as the…

Continue Reading

Blog

Supporting the rapid launch of pharmaceutical and biopharma products: a contract packaging perspective

Product launches see pharma and biotech companies handing over drugs with incredible value, both commercially and to the health of patients globally, to contract…

Continue Reading

Sharp has partnered with @BerkshireSM to provide clients with a seamless, end-to-end #pharmaceutical manufacturing, packaging & distribution solution.

Learn more about how our combined expertise can benefit your project: https://lnkd.in/eW4QmJm

Are you registered for tomorrow's webinar?

Don’t miss your opportunity to hear from our experts as they discuss both the internal & external forces impacting the scaling of #clinical & #commercial drugs and how to avoid these pitfalls.

Register here: https://lnkd.in/eHFmUh8

Sharp has appointed Ria Rhemrev-Boom as its new lead EU Qualified Person (QP) for market release services.

https://www.sharpservices.com/resources/news/sharp-appoints-eu-qualified-person/

#QualifiedPerson #MarketRelease #QualityManagement